Publications

  1. Weivoda MM, Oursler MJ. Developments in sclerostin biology: regulation of gene expression, mechanisms of action, and physiological functions. Curr Osteoporos Rep. 2014 Mar; 12(1):107-14.
    View PubMed
  2. Ota K, Quint P, Weivoda MM, Ruan M, Pederson L, Westendorf JJ, Khosla S, Oursler MJ. Transforming growth factor beta 1 induces CXCL16 and leukemia inhibitory factor expression in osteoclasts to modulate migration of osteoblast progenitors. Bone. 2013 Nov; 57(1):68-75. Epub 2013 Jul 25.
    View PubMed
  3. Ota K, Quint P, Ruan M, Pederson L, Westendorf JJ, Khosla S, Oursler MJ. TGF-beta induces Wnt10b in osteoclasts from female mice to enhance coupling to osteoblasts. Endocrinology. 2013 Oct; 154(10):3745-52. Epub 2013 Jul 16.
    View PubMed
  4. Ota K, Quint P, Ruan M, Pederson L, Westendorf JJ, Khosla S, Oursler MJ. Sclerostin is expressed in osteoclasts from aged mice and reduces osteoclast-mediated stimulation of mineralization. J Cell Biochem. 2013 Aug; 114(8):1901-7.
    View PubMed
  5. van Wijnen AJ, van de Peppel J, van Leeuwen JP, Lian JB, Stein GS, Westendorf JJ, Oursler MJ, Im HJ, Taipaleenmaki H, Hesse E, Riester S, Kakar S. MicroRNA functions in osteogenesis and dysfunctions in osteoporosis. Curr Osteoporos Rep. 2013 Jun; 11(2):72-82.
    View PubMed
  6. Quint P, Ruan M, Pederson L, Kassem M, Westendorf JJ, Khosla S, Oursler MJ. Sphingosine 1-phosphate (S1P) receptors 1 and 2 coordinately induce mesenchymal cell migration through S1P activation of complementary kinase pathways. J Biol Chem. 2013 Feb 22; 288(8):5398-406. Epub 2013 Jan 07.
    View PubMed
  7. Khosla S, Oursler MJ, Monroe DG. Estrogen and the skeleton. Trends Endocrinol Metab. 2012 Nov; 23(11):576-81. Epub 2012 May 16.
    View PubMed
  8. Monroe DG, McGee-Lawrence ME, Oursler MJ, Westendorf JJ. Update on Wnt signaling in bone cell biology and bone disease. Gene. 2012 Jan 15; 492(1):1-18. Epub 2011 Nov 03.
    View PubMed
  9. Kumar A, Ruan M, Clifton K, Syed F, Khosla S, Oursler MJ. TGF-beta mediates suppression of adipogenesis by estradiol through connective tissue growth factor induction. Endocrinology. 2012 Jan; 153(1):254-63. Epub 2011 Nov 08.
    View PubMed
  10. Modder UI, Roforth MM, Hoey K, McCready LK, Peterson JM, Monroe DG, Oursler MJ, Khosla S. Effects of estrogen on osteoprogenitor cells and cytokines/bone-regulatory factors in postmenopausal women. Bone. 2011 Aug; 49(2):202-7. Epub 2011 Apr 29.
    View PubMed
  11. Modder UI, Oursler MJ, Khosla S, Monroe DG. Wnt10b activates the Wnt, notch, and NFkappaB pathways in U2OS osteosarcoma cells. J Cell Biochem. 2011 May; 112(5):1392-402.
    View PubMed
  12. Modder UI, Clowes JA, Hoey K, Peterson JM, McCready L, Oursler MJ, Riggs BL, Khosla S. Regulation of circulating sclerostin levels by sex steroids in women and in men. J Bone Miner Res. 2011 Jan; 26(1):27-34.
    View PubMed
  13. Cicek M, Vrabel A, Sturchio C, Pederson L, Hawse JR, Subramaniam M, Spelsberg TC, Oursler MJ. TGF-beta inducible early gene 1 regulates osteoclast differentiation and survival by mediating the NFATc1, AKT, and MEK/ERK signaling pathways. PLoS One. 2011; 6(3):e17522. Epub 2011 Mar 14.
    View PubMed
  14. Hawse JR, Cicek M, Grygo SB, Bruinsma ES, Rajamannan NM, van Wijnen AJ, Lian JB, Stein GS, Oursler MJ, Subramaniam M, Spelsberg TC. TIEG1/KLF10 modulates Runx2 expression and activity in osteoblasts. PLoS One. 2011; 6(4):e19429. Epub 2011 Apr 29.
    View PubMed
  15. Syed FA, Modder UI, Roforth M, Hensen I, Fraser DG, Peterson JM, Oursler MJ, Khosla S. Effects of chronic estrogen treatment on modulating age-related bone loss in female mice. J Bone Miner Res. 2010 Nov; 25(11):2438-46.
    View PubMed
  16. Oursler MJ. Recent advances in understanding the mechanisms of osteoclast precursor fusion. J Cell Biochem. 2010 Aug 1; 110(5):1058-62.
    View PubMed
  17. Ruan M, Pederson L, Bradley EW, Bamberger AM, Oursler MJ. Transforming growth factor-{beta} coordinately induces suppressor of cytokine signaling 3 and leukemia inhibitory factor to suppress osteoclast apoptosis. Endocrinology. 2010 Apr; 151(4):1713-22. Epub 2010 Feb 24.
    View PubMed
  18. Subramaniam M, Hawse JR, Bruinsma ES, Grygo SB, Cicek M, Oursler MJ, Spelsberg TC. TGFbeta inducible early gene-1 directly binds to, and represses, the OPG promoter in osteoblasts. Biochem Biophys Res Commun. 2010 Jan 29; 392(1):72-6. Epub 2010 Jan 06.
    View PubMed
  19. Subramaniam M, Hawse JR, Bruinsma ES, Grygo SB, Cicek M, Oursler MJ, Spelsberg TC. TGF beta inducible early gene-1 directly binds to, and represses, the OPG promoter in osteoblasts. Biochem Biophys Res Commun. 2010; 392(1):72-6.
    View PubMed
  20. Clowes JA, Eghbali-Fatourechi GZ, McCready L, Oursler MJ, Khosla S, Riggs BL. Estrogen action on bone marrow osteoclast lineage cells of postmenopausal women in vivo. Osteoporos Int. 2009 May; 20(5):761-9. Epub 2008 Sep 04.
    View PubMed
  21. Pederson L, Ruan M, Westendorf JJ, Khosla S, Oursler MJ. Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. Proc Natl Acad Sci U S A. 2008 Dec 30; 105(52):20764-9. Epub 2008 Dec 15.
    View PubMed
  22. Bradley EW, Ruan MM, Oursler MJ. PAK1 is a novel MEK-independent raf target controlling expression of the IAP survivin in M-CSF-mediated osteoclast survival. J Cell Physiol. 2008 Dec; 217(3):752-8.
    View PubMed
  23. Gingery A, Bradley EW, Pederson L, Ruan M, Horwood NJ, Oursler MJ. TGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival. Exp Cell Res. 2008 Sep 10; 314(15):2725-38. Epub 2008 Jun 13.
    View PubMed
  24. Syed FA, Oursler MJ, Hefferanm TE, Peterson JM, Riggs BL, Khosla S. Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women. Osteoporos Int. 2008 Sep; 19(9):1323-30. Epub 2008 Feb 15.
    View PubMed
  25. Bradley EW, Ruan MM, Vrable A, Oursler MJ. Pathway crosstalk between Ras/Raf and PI3K in promotion of M-CSF-induced MEK/ERK-mediated osteoclast survival. J Cell Biochem. 2008 Jul 1; 104(4):1439-51.
    View PubMed
  26. Hawse JR, Subramaniam M, Monroe DG, Hemmingsen AH, Ingle JN, Khosla S, Oursler MJ, Spelsberg TC. Estrogen receptor beta isoform-specific induction of transforming growth factor beta-inducible early gene-1 in human osteoblast cells: an essential role for the activation function 1 domain. Mol Endocrinol. 2008 Jul; 22(7):1579-95. Epub 2008 May 15.
    View PubMed
  27. Hawse JR, Iwaniec UT, Bensamoun SF, Monroe DG, Peters KD, Ilharreborde B, Rajamannan NM, Oursler MJ, Turner RT, Spelsberg TC, Subramaniam M. TIEG-null mice display an osteopenic gender-specific phenotype. Bone. 2008 Jun; 42(6):1025-31. Epub 2008 Mar 04.
    View PubMed
  28. Sanyal A, Hoey KA, Modder UI, Lamsam JL, McCready LK, Peterson JM, Achenbach SJ, Oursler MJ, Khosla S. Regulation of bone turnover by sex steroids in men. J Bone Miner Res. 2008 May; 23(5):705-14.
    View PubMed
  29. Bradley EW, Ruan MM, Oursler MJ. Novel pro-survival functions of the Kruppel-like transcription factor Egr2 in promotion of macrophage colony-stimulating factor-mediated osteoclast survival downstream of the MEK/ERK pathway. J Biol Chem. 2008 Mar 21; 283(12):8055-64. Epub 2008 Jan 15.
    View PubMed
  30. Rudnik V, Sanyal A, Syed FA, Monroe DG, Spelsberg TC, Oursler MJ, Khosla S. Loss of ERE binding activity by estrogen receptor-alpha alters basal and estrogen-stimulated bone-related gene expression by osteoblastic cells. J Cell Biochem. 2008 Feb 15; 103(3):896-907.
    View PubMed
  31. Hawse JR, Subramaniam M, Ingle JN, Oursler MJ, Rajamannan NM, Spelsberg TC. Estrogen-TGFbeta cross-talk in bone and other cell types: role of TIEG, Runx2, and other transcription factors. J Cell Biochem. 2008 Feb 1; 103(2):383-92.
    View PubMed
  32. Khosla S, Westendorf JJ, Oursler MJ. Building bone to reverse osteoporosis and repair fractures. J Clin Invest. 2008 Feb; 118(2):421-8.
    View PubMed
  33. Bradley EW, Oursler MJ. Osteoclast culture and resorption assays. Methods Mol Biol. 2008; 455:19-35.
    View PubMed
  34. Cicek M, Iwaniec UT, Goblirsch MJ, Vrabel A, Ruan M, Clohisy DR, Turner RR, Oursler MJ. 2-Methoxyestradiol suppresses osteolytic breast cancer tumor progression in vivo. Cancer Res. 2007 Nov 1; 67(21):10106-11.
    View PubMed
  35. Cicek M, Iwaniec UT, Goblirsch M, Vrabel A, Ruan M, Clohisy DC, Turner R, Oursler MJ. 2-Methoxyestradiol Suppressed Ostolytic Breast Cancer Tumor Progression In Vivo Cancer Research. 2007.
  36. Bensamoun SF, Hawse JR, Subramaniam M, Ilharreborde B, Bassillais A, Benhamou CL, Fraser DG, Oursler MJ, Amadio PC, An KN, Spelsberg TC. TGFbeta inducible early gene-1 knockout mice display defects in bone strength and microarchitecture. Bone. 2006 Dec; 39(6):1244-51. Epub 2006 Jul 28.
    View PubMed
  37. Bensamoun SF, Hawse JR, Subramaniam M, Ilharreborde B, Bassillais A, Benhamou CL, Fraser DG, Oursler MJ, Amadio PC, An KN, Spelsberg TC. TGF beta inducible early gene-1 knockout mice display defects in bone strength and microarchitecture. Bone. 2006 Dec; 39(6):1244-51.
    View PubMed
  38. Cicek M, Oursler MJ. Breast cancer bone metastasis and current small therapeutics. Cancer Metastasis Rev. 2006 Dec; 25(4):635-44.
    View PubMed
  39. Maran A, Gorny G, Oursler MJ, Zhang M, Shogren KL, Yaszemski MJ, Turner RT. 2-methoxyestradiol inhibits differentiation and is cytotoxic to osteoclasts. J Cell Biochem. 2006 Oct 1; 99(2):425-34.
    View PubMed
  40. Lotinun S, Evans GL, Turner RT, Oursler MJ. Deletion of membrane-bound steel factor results in osteopenia in mice. J Bone Miner Res. 2005 Apr; 20(4):644-52.
    View PubMed
  41. Subramaniam M, Gorny G, Johnsen SA, Monroe DG, Evans GL, Fraser DG, Rickard DJ, Rasmussen K, van Deursen JM, Turner RT, Oursler MJ, Spelsberg TC. TIEG1 null mouse-derived osteoblasts are defective in mineralization and in support of osteoclast differentiation in vitro. Mol Cell Biol. 2005 Feb; 25(3):1191-9.
    View PubMed
  42. Oursler MJ, Bradley EW, Elfering SL, Giulivi C. Native, not nitrated, cytochrome c and mitochondria-derived hydrogen peroxide drive osteoclast apoptosis. Am J Physiol Cell Physiol. 2005 Jan; 288(1):C156-68.
    View PubMed
  43. Karst M, Gorny G, Galvin RJ, Oursler MJ. Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiation. J Cell Physiol. 2004 Jul; 200(1):99-106.
    View PubMed
  44. Gorny G, Shaw A, Oursler MJ. IL-6, LIF, and TNF-alpha regulation of GM-CSF inhibition of osteoclastogenesis in vitro. Exp Cell Res. 2004 Mar 10; 294(1):149-58.
    View PubMed
  45. Gingery A, Bradley E, Shaw A, Oursler MJ. Phosphatidylinositol 3-kinase coordinately activates the MEK/ERK and AKT/NFkappaB pathways to maintain osteoclast survival. J Cell Biochem. 2003 May 1; 89(1):165-79.
    View PubMed
  46. Mizuta H, Sanyal A, Fukumoto T, Fitzsimmons JS, Matsui N, Bolander ME, Oursler MJ, O'Driscoll SW. The spatiotemporal expression of TGF-beta1 and its receptors during periosteal chondrogenesis in vitro. J Orthop Res. 2002 May; 20(3):562-74.
    View PubMed
  47. Sanyal A, Oursler MJ, Clemens VR, Fukumoto T, Fitzsimmons JS, O'Driscoll SW. Temporal expression patterns of BMP receptors and collagen II (B) during periosteal chondrogenesis. J Orthop Res. 2002 Jan; 20(1):58-65.
    View PubMed
  48. Gingery A, Oursler MJ. The roles of TGF-beta in metastatic cancer progression in bone. Recent Research Developments in Cancer. 2002; 4(13-24).
    View PubMed
  49. Pascoe D, Oursler MJ. The Src signaling pathway regulates osteoclast lysosomal enzyme secretion and is rapidly modulated by estrogen. J Bone Miner Res. 2001 Jun; 16(6):1028-36.
    View PubMed
  50. Winding B, Misander H, Sveigaard C, Therkildsen B, Jakobsen M, Overgaard T, Oursler MJ, Foged NT. Human breast cancer cells induced angiogenesis, recruitment, and activation of osteoclasts in osteolytic metastasis. Journal of Cancer Research & Clinical Oncology. 2000 Nov; 126(11):631-40.
    View PubMed
  51. Shaw A, Oursler MJ. Paracrine regulation of osteoclast activity in metastatic breast cancer. Cancer Research Alert. 2000; 1:124-7.
    View PubMed
  52. Pederson L, Winding B, Foged NT, Spelsberg TC, Oursler MJ. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity. Cancer Res. 1999 Nov 15; 59(22):5849-55.
    View PubMed
  53. Pederson L, Kremer M, Judd J, Pascoe D, Spelsberg TC, Riggs BL, Oursler MJ. Androgens regulate bone resorption activity of isolated osteoclasts in vitro. Proc Natl Acad Sci U S A. 1999 Jan 19; 96(2):505-10.
    View PubMed
  54. Oursler MJ. Mechanisms of steroid action on osteoclasts and osteoblasts. Biochem Soc Trans. 1998 Feb; 26(1):33-8.
    View PubMed
  55. Collin-Osdoby P, Li L, Rothe L, Anderson F, Kirsch D, Oursler MJ, Osdoby P. Inhibition of avian osteoclast bone resorption by monoclonal antibody 121F: a mechanism involving the osteoclast free radical system. J Bone Miner Res. 1998 Jan; 13(1):67-78.
    View PubMed
  56. Oursler MJ. Estrogen regulation of gene expression in osteoblasts and osteoclasts. Crit Rev Eukaryot Gene Expr. 1998; 8(2):125-40.
    View PubMed
  57. Pederson L, Kremer M, Foged NT, Winding B, Ritchie C, Fitzpatrick LA, Oursler MJ. Evidence of a correlation of estrogen receptor level and avian osteoclast estrogen responsiveness. J Bone Miner Res. 1997 May; 12(5):742-52.
    View PubMed
  58. Clohisy DR, Palkert D, Ramnaraine ML, Pekurovsky I, Oursler MJ. Human breast cancer induces osteoclast activation and increases the number of osteoclasts at sites of tumor osteolysis. J Orthop Res. 1996 May; 14(3):396-402.
    View PubMed
  59. Robinson JA, Riggs BL, Spelsberg TC, Oursler MJ. Osteoclasts and transforming growth factor-beta: estrogen-mediated isoform-specific regulation of production. Endocrinology. 1996 Feb; 137(2):615-21.
    View PubMed
  60. Subramaniam M, Harris SA, Oursler MJ, Rasmussen K, Riggs BL, Spelsberg TC. Identification of a novel TGF-beta-regulated gene encoding a putative zinc finger protein in human osteoblasts. Nucleic Acids Res. 1995 Dec 11; 23(23):4907-12.
    View PubMed
  61. Schutze N, Oursler MJ, Nolan J, Riggs BL, Spelsberg TC. Zeolite A inhibits osteoclast-mediated bone resorption in vitro. J Cell Biochem. 1995 May; 58(1):39-46.
    View PubMed
  62. Kremer M, Judd J, Rifkin B, Auszmann J, Oursler MJ. Estrogen modulation of osteoclast lysosomal enzyme secretion. J Cell Biochem. 1995 Feb; 57(2):271-9.
    View PubMed
  63. Collin-Osdoby P, Oursler MJ, Rothe L, Webber D, Anderson F, Osdoby P. Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity. J Bone Miner Res. 1995 Jan; 10(1):45-58.
    View PubMed
  64. Subramaniam M, Oursler MJ, Rasmussen K, Riggs BL, Spelsberg TC. TGF-beta regulation of nuclear proto-oncogenes and TGF-beta gene expression in normal human osteoblast-like cells. J Cell Biochem. 1995 Jan; 57(1):52-61.
    View PubMed
  65. Judd J, Kremer M, Oursler MJ. Age dependence of estrogen responsiveness. Calcif Tissue Int. 1995; 56 Suppl 1:S25-6.
    View PubMed
  66. Khosla S, Oursler MJ, Schroeder MJ, Eberhardt NL. Transforming growth factor-beta 1 induces growth inhibition of a human medullary thyroid carcinoma cell line despite an increase in steady state c-myc messenger ribonucleic acid levels. Endocrinology. 1994 Nov; 135(5):1887-93.
    View PubMed
  67. Oursler MJ, Pederson L, Fitzpatrick L, Riggs BL, Spelsberg T. Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells. Proc Natl Acad Sci U S A. 1994 Jun 7; 91(12):5227-31.
    View PubMed
  68. Oursler MJ. Osteoclast synthesis and secretion and activation of latent transforming growth factor beta. J Bone Miner Res. 1994 Apr; 9(4):443-52.
    View PubMed
  69. Sarrel PM, Lufkin EG, Oursler MJ, Keefe D. Estrogen actions in arteries, bone, and brain. Scientific American Science and Medicine. 1994; 1(3):44-53.
  70. Oursler MJ, Riggs BL, Spelsberg TC. Glucocorticoid-induced activation of latent transforming growth factor-beta by normal human osteoblast-like cells. Endocrinology. 1993 Nov; 133(5):2187-96.
    View PubMed
  71. Oursler MJ, Landers JP, Riggs BL, Spelsberg TC. Oestrogen effects on osteoblasts and osteoclasts. Ann Med. 1993 Aug; 25(4):361-71.
    View PubMed
  72. Oursler MJ, Pederson L, Pyfferoen J, Osdoby P, Fitzpatrick L, Spelsberg TC. Estrogen modulation of avian osteoclast lysosomal gene expression. Endocrinology. 1993 Mar; 132(3):1373-80.
    View PubMed
  73. Oursler MJ, Riggs BL, Fitzpatrick L, Spelsberg TC. Estrogen action on bone cells: the osteoclasts. Fourth International Symposium on Osteoporosis. 1993; 386-91.
  74. Keeting PE, Oursler MJ, Wiegand KE, Bonde SK, Spelsberg TC, Riggs BL. Zeolite A increases proliferation, differentiation, and transforming growth factor beta production in normal adult human osteoblast-like cells in vitro. J Bone Miner Res. 1992 Nov; 7(11):1281-9.
    View PubMed
  75. Greenfield EM, Alvarez JI, McLaurine EA, Oursler MJ, Blair HC, Osdoby P, Teitelbaum SL, Ross FP. Avian osteoblast conditioned media stimulate bone resorption by targeting multinucleating osteoclast precursors. Calcif Tissue Int. 1992 Oct; 51(4):317-23.
    View PubMed
  76. Keeting PE, Scott RE, Colvard DS, Anderson MA, Oursler MJ, Spelsberg TC, Riggs BL Jr. Development and characterization of a rapidly proliferating, well-differentiated cell line derived from adult human osteoblast-like cells transfected with SV40 large T antigen. J Bone Miner Res. 1992 Feb; 7:127-36.
    View PubMed
  77. Osdoby P, Oursler MJ, Pyfferoen J, Riggs BL Jr, Spelsberg TC. The regulation of osteoclast activity. Int Congr Ser. 1992; 1002:339-46.
  78. Collin-Osdoby P, Oursler MJ, Webber D, Osdoby P. Osteoclast-specific monoclonal antibodies coupled to magnetic beads provide a rapid and efficient method of purifying avian osteoclasts. J Bone Miner Res. 1991 Dec; 6(12):1353-65.
    View PubMed
  79. Oursler MJ, Cortese C, Keeting P, Anderson MA, Bonde SK, Riggs BL, Spelsberg TC. Modulation of transforming growth factor-beta production in normal human osteoblast-like cells by 17 beta-estradiol and parathyroid hormone. Endocrinology. 1991 Dec; 129(6):3313-20.
    View PubMed
  80. Oursler MJ, Osdoby P, Pyfferoen J, Riggs BL, Spelsberg TC. Avian osteoclasts as estrogen target cells. Proc Natl Acad Sci U S A. 1991 Aug 1; 88(15):6613-7.
    View PubMed
  81. Oursler MJ, Collin-Osdoby P, Li L, Schmitt E, Osdoby P. Evidence for an immunological and functional relationship between superoxide dismutase and a high molecular weight osteoclast plasma membrane glycoprotein. J Cell Biochem. 1991 Aug; 46(4):331-44.
    View PubMed
  82. Oursler MJ, Li L, Osdoby P. Purification and characterization of an osteoclast membrane glycoprotein with homology to manganese superoxide dismutase. J Cell Biochem. 1991 Jul; 46(3):219-33.
    View PubMed
  83. Oursler MJ, Collin-Osdoby P, Anderson F, Li L, Webber D, Osdoby P. Isolation of avian osteoclasts: improved techniques to preferentially purify viable cells. J Bone Miner Res. 1991 Apr; 6(4):375-85.
    View PubMed
  84. Oursler MJ, Osdoby P. Characterization of an osteoclast membrane protein related to superoxide dismutase. Excerpta Medica: International Congress Series. 1990; 886(10):214-20.
  85. Oursler MJ, Osdoby P. Osteoclast development in marrow cultured in calvaria-conditioned media. Dev Biol. 1988 May; 127(1):170-8.
    View PubMed
  86. Osdoby P, Oursler MJ, Salino-Hugg T, Krukowski M. Osteoclast development: the cell surface and the bone environment. Ciba Found Symp. 1988; 136:108-24.
    View PubMed
  87. Osdoby P, Krukowski M, Oursler MJ, Salino-Hugg T. The origin, development and regulation of osteoclasts. Bioessays. 1987 Jul; 7(1):30-4.
    View PubMed
  88. Oursler MJ, Bell LV, Clevinger B, Osdoby P. Identification of osteoclast-specific monoclonal antibodies. J Cell Biol. 1985 May; 100(5):1592-600.
    View PubMed
  89. Richter GW, Velasquez MJ, Shedd R. Ferritin in rat kidneys with specific lesions due to a single dose of lead. Am J Pathol. 1979 Mar; 94(3):483-95.
    View PubMed